These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15332755)

  • 21. Epidemiology of varicella hospitalizations in the United States, 1995-2005.
    Reynolds MA; Watson BM; Plott-Adams KK; Jumaan AO; Galil K; Maupin TJ; Zhang JX; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S120-6. PubMed ID: 18419384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005.
    Lin YH; Huang LM; Chang IS; Tsai FY; Chang LY
    J Microbiol Immunol Infect; 2009 Feb; 42(1):5-12. PubMed ID: 19424552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A seroepidemiology study of varicella among children aged 0-12 years in Taiwan.
    Tseng HF; Tan HF; Chang CK; Wang LY; Yang SE; Liau MY; Pan MJ; Chen CY; Huang SP
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1201-7. PubMed ID: 16438146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella.
    Mullooly JP; Maher JE; Drew L; Schuler R; Hu W
    Vaccine; 2004 Mar; 22(11-12):1480-5. PubMed ID: 15063572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successes and remaining challenges after 10 years of varicella vaccination in the USA.
    Davis MM
    Expert Rev Vaccines; 2006 Apr; 5(2):295-302. PubMed ID: 16608428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella outbreak epidemiology in an active surveillance site, 1995-2005.
    Civen R; Lopez AS; Zhang J; Garcia-Herrera J; Schmid DS; Chaves SS; Mascola L
    J Infect Dis; 2008 Mar; 197 Suppl 2():S114-9. PubMed ID: 18419383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of varicella immune status in an obstetric population in relation to place of birth.
    Goldberg JM; Ziel HK; Burchette R
    Am J Perinatol; 2002 Oct; 19(7):387-94. PubMed ID: 12442228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of varicella in southern Taiwan: a life table method estimation among susceptible population.
    Tan HF; Tseng HF; Chang CK; Ke D; Lee-Hsieh J
    Vaccine; 2004 Jul; 22(21-22):2730-6. PubMed ID: 15246604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey.
    Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD
    Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation.
    Marshall H; Ryan P; Roberton D
    Vaccine; 2005 Nov; 23(46-47):5389-97. PubMed ID: 16039020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994.
    Meyer PA; Seward JF; Jumaan AO; Wharton M
    J Infect Dis; 2000 Aug; 182(2):383-90. PubMed ID: 10915066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-specific incidence of chickenpox.
    Finger R; Hughes JP; Meade BJ; Pelletier AR; Palmer CT
    Public Health Rep; 1994; 109(6):750-5. PubMed ID: 7800783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
    Guris D; Jumaan AO; Mascola L; Watson BM; Zhang JX; Chaves SS; Gargiullo P; Perella D; Civen R; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S71-5. PubMed ID: 18419413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.
    Jumaan AO; Yu O; Jackson LA; Bohlke K; Galil K; Seward JF
    J Infect Dis; 2005 Jun; 191(12):2002-7. PubMed ID: 15897984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
    Savaş S; Dallar Y; Arikan I; Onde U
    Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.